Accrelist (SGX:QZG) Total Liabilities: S$9.91 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:QZG Accrelist Ltd SGX:QZG
26 GF Score
Price S$0.10
GF Value S$0.04
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Accrelist Total Liabilities?

Accrelist SGX:QZG -10.00% 26 Total Liabilities is S$9.91 Mil as of Mar. 2026. GuruFocus rates SGX:QZG with a GF Score™ of 26/100 and a GF Value™ of S$0.04 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Accrelist's Total Liabilities for the quarter that ended in Mar. 2026 was S$9.91 Mil.

Accrelist's quarterly Total Liabilities increased from Mar. 2025 (S$9.80 Mil) to Sep. 2025 (S$10.13 Mil) but then declined from Sep. 2025 (S$10.13 Mil) to Mar. 2026 (S$9.91 Mil).

Accrelist's annual Total Liabilities increased from Mar. 2024 (S$9.51 Mil) to Mar. 2025 (S$9.80 Mil) and increased from Mar. 2025 (S$9.80 Mil) to Mar. 2026 (S$9.91 Mil).

Accrelist Total Liabilities Historical Data

* Premium members only.

The historical data trend for Accrelist's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accrelist Total Liabilities Chart

Accrelist Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.04 34.35 9.51 9.80 9.91

Accrelist Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.51 7.91 9.80 10.13 9.91
SGX:QZG
26GF Score
Accrelist Ltd SGX:QZG
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accrelist Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Accrelist's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.674+(1.238+1.3322676295502E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.91

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=21.532-11.62
=9.91

Accrelist's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.674+(1.238+1.3322676295502E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.91

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=21.532-11.62
=9.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of S$9.91 Mil mean?
Accrelist (SGX:QZG) has a Total Liabilities of S$9.91 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Accrelist and its competitors.
Is Accrelist's Total Liabilities too high?
Accrelist's current Total Liabilities is S$9.91 Mil. Overall, Accrelist has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Accrelist's Total Liabilities compare to HCA and THC?
Accrelist's Total Liabilities of S$9.91 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Accrelist and its competitors. Accrelist's current Total Liabilities is S$9.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accrelist stock overvalued right now?
Based on GuruFocus' analysis, Accrelist (SGX:QZG) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.04, compared to a current price of S$0.10 — trading 147.5% above its estimated fair value. The current Total Liabilities is S$9.91 Mil. Accrelist's overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Accrelist (SGX:QZG), the current Total Liabilities is S$9.91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accrelist (SGX:QZG) Overvalued in 2026?

Based on GuruFocus' analysis, Accrelist stock appears to be overvalued. The current stock price of S$0.10 is trading 147.5% above its estimated GF Value™ of S$0.04. GuruFocus considers Accrelist to be Significantly Overvalued.

Key valuation signals for SGX:QZG:

  • Total Liabilities: S$9.91 Mil
  • GF Value™: S$0.04 vs. price of S$0.10 (147.5% above fair value)
  • GF Score™: 26/100 with 6 warning signs

No single metric tells the full story. See the SGX:QZG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accrelist Business Description

Address 10 Ubi Crescent, Ubi Techpark, Lobby E No. 03-95, Singapore, SGP, 408564
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.
26GF Score

Get the complete analysis for SGX:QZG

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.10
Price
S$0.04
GF Value